Systematic Review of Cost-Effectiveness Analysis for Surgical and Neurostimulation Treatments for Drug-Resistant Epilepsy in Adults.
Nicholas Ngan KeeEmma FosterClara MarquinaAndy TanSamantha S T PangTerence J O'BrienPatrick KwanGraeme D JacksonZhibin Chen MBiostatZanfina AdemiPublished in: Neurology (2023)
There is consistent evidence that epilepsy surgery is a cost-effective treatment for eligible candidates with DRE. Limited evidence suggests that VNS, RNS, and DBS may be cost-effective therapies for DRE, although more health economic evaluations alongside prospective clinical trials are needed to validate these findings.
Keyphrases
- drug resistant
- systematic review
- multidrug resistant
- clinical trial
- acinetobacter baumannii
- minimally invasive
- public health
- healthcare
- meta analyses
- coronary artery bypass
- mental health
- randomized controlled trial
- coronary artery disease
- cystic fibrosis
- pseudomonas aeruginosa
- climate change
- combination therapy
- smoking cessation
- atrial fibrillation
- percutaneous coronary intervention
- phase iii